A 27-year-old woman with a history of recurrent nephrolithiasis presented with right flank and suprapubic pain for 4-day duration. She also complained of fever and chills. She had a right ureteral double J stent placed 3 years prior to presentation for right-sided urolithiasis. The stent was not exchanged or removed during this period as she was lost to follow-up with the urologist. She had a fever of 38.2°C, and other vital signs were normal. Physical examination was unremarkable except for tenderness in the right costo-vertebral angle. Urinalysis revealed about 1600 white blood cells and 400 red blood cells per high power field. She was admitted to the hospital, and started on intravenous antibiotics for pyelonephritis. Later, urine culture grew more than 100,000 col/ml Klebsiella pneumoniae. An abdominal computed tomography (CT) scan was obtained on day 3 of admission because of persistent abdominal pain and fever, to rule out possible perinephric abscess. It showed right pelvi-ureteral junction nephrolithiasis with an encrusted right ureteral stent, and a large bladder stone (Figs. 1, 2). Cystoscopy showed a large, free floating *6 cm spherical stone within the bladder. She subsequently underwent cystolithalopaxy, laser lithotripsy, right percutaneous nephrolithotomy and removal of the distal retained stent. Most of the stone burden including the bladder and uretero-pelvic junction stones was removed. Stone analysis revealed carbonate apatite and magnesium ammonium phosphate hexahydrate.
Ureteral stents have become the mainstay of treatment of ureteral obstruction. Stent migration, fragmentation and encrustation are the common late complications associated with them [1] . Ureteric stent encrustation is often associated with a stent indwelling time of more than 12 weeks [2] , alkaline urine, urinary tract infections, poor compliance and congenital renal anomalies [3] . The underlying mechanism of encrustation is that the urinary proteins and bacterial products adhere to the stent surface leading to a biofilm formation that in turn, leads to calcium and oxalate precipitation. The presence of a foreign body (that is, the lower portion of the ureteral stent) in the urinary bladder increases the risk of recurrent urinary tract infections, thereby biofilm formation and bladder stone formation [4] . The most common stones associated with encrustation are calcium oxalate (69.1%) and carbapatite (15.5%) [5] . Management of encrusted stents remains challenging, and timely removal or exchange of ureteral catheters should minimize risk of stent calcification. Patient education and maintenance of a computerized registry to prevent 'forgotten stents' may play a key role in prevention.
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